Nopixglobal AG, Schweiz, ist die exklusive Inhaberin der Lizenz für  nopixgo®  und für weitere Produkte, die von Erfinder und Forscher Kurt Stoll und der Nobilab GmbH entwickelt werden.  

Nopixglobal AG is introducing the product onto Western markets one step at a time. By using more economical production methods, the aim is to achieve a high sales volume in order to enable the product to be distributed worldwide at the lowest possible price – particularly in regions where people are affected by vector-borne diseases.

nopixgo® was developed in Switzerland by Nobilab GmbH. Established Swiss partner firms such as WERAP and VONALLMEN produce the high-tech wristbands and guarantee top Swiss quality.

Demo Logo
Demo Logo
Demo Logo
Demo Logo